Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: Implications for angiogenesis and vasculogenesis

Journal of Thoracic and Cardiovascular Surgery

Volumn 146, Issue 4, 2013, Pages 971-978

  Tepeköylü, Can ^a   Wang, Feng Sheng ^b,c   Kozaryn, Radoslaw ^a   Albrecht Schgoer, Karin ^a   Theurl, Markus ^a   Schaden, Wolfgang ^d   Ke, Huei Jin ^b   Yang, Yaju ^b   Kirchmair, Rudolf ^a   Grimm, Michael ^a   Wang, Ching Jen ^b,c   Holfeld, Johannes ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d AUVA Soziale Unfallversicherung   (Austria)

Author keywords

control; Ct; CTR; cycle threshold; endothelial progenitor cell; EPC; HIF 1 ; hypoxia inducible factor 1 ; PCNA; proliferating cell nuclear antigen; SDF 1; shock wave therapy; stromal cell derived factor 1; SWT; vascular endothelial growth factor; VEGF

Indexed keywords

ANGIOGENIC FACTOR; CD31 ANTIGEN; CD34 ANTIGEN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY LIGATION; ARTICLE; CELL MOTILITY; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; EXTRACORPOREAL LITHOTRIPSY; FLUORESCENCE ACTIVATED CELL SORTING; LIMB ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT;

39.2; 39.4; CONTROL; CT; CTR; CYCLE THRESHOLD; ENDOTHELIAL PROGENITOR CELL; EPC; HIF-1Α; HYPOXIA-INDUCIBLE FACTOR 1Α; PCNA; PROLIFERATING CELL NUCLEAR ANTIGEN; SDF-1; SHOCK WAVE THERAPY; STROMAL CELL-DERIVED FACTOR-1; SWT; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF;

ANIMALS; ANTIGENS, CD31; ANTIGENS, CD34; BIOLOGICAL MARKERS; CELL MOVEMENT; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HIGH-ENERGY SHOCK WAVES; HINDLIMB; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIA; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CXCR4; RECOVERY OF FUNCTION; REGIONAL BLOOD FLOW; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884415373     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.01.017     Document Type: Article

References (21)

1. Y. Wang, T. Guo, H.Y. Cai, T.K. Ma, S.M. Tao, and S. Sun Cardiac shock wave therapy reduces angina and improves myocardial function in patients with refractory coronary artery disease Clin Cardiol 33 2010 693 699
2. D. Zimpfer, S. Aharinejad, J. Holfeld, A. Thomas, J. Dumfarth, and R. Rosenhek Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure J Thorac Cardiovasc Surg 137 2009 963 970
3. C. Ottomann, A. Stojadinovic, P.T. Lavin, F.H. Gannon, M.H. Heggeness, and R. Thiele Prospective randomized phase II trial of accelerated reepithelialization of superficial second-degree burn wounds using extracorporeal shock wave therapy Ann Surg 255 2012 23 29
4. R. Mittermayr, J. Hartinger, V. Antonic, A. Meinl, S. Pfeifer, and A. Stojadinovic Extracorporeal shock wave therapy (ESWT) minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis Ann Surg 253 2011 1024 1032
5. A. Aicher, C. Heeschen, K. Sasaki, C. Urbich, A.M. Zeiher, and S. Dimmeler Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia Circulation 114 2006 2823 2830 (Pubitemid 46018285)
6. K.H. Yeh, J.J. Sheu, Y.C. Lin, C.K. Sun, L.T. Chang, and Y.H. Kao Benefit of combined extracorporeal shock wave and bone marrow-derived endothelial progenitor cells in protection against critical limb ischemia in rats Crit Care Med 40 2012 169 177
7. T. Couffinhal, M. Silver, L.P. Zheng, M. Kearney, B. Witzenbichler, and J.M. Isner Mouse model of angiogenesis Am J Pathol 152 1998 1667 1679 (Pubitemid 28275025)
8. F.P. Hamers, A.J. Lankhorst, T.J. van Laar, W.B. Veldhuis, and W.H. Gispen Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries J Neurotrauma 18 2001 187 201 (Pubitemid 32173426)
9. G.C. Koopmans, R. Deumens, W.M. Honig, F.P. Hamers, H.W. Steinbusch, and E.A. Joosten The assessment of locomotor function in spinal cord injured rats: the importance of objective analysis of coordination J Neurotrauma 22 2005 214 225 (Pubitemid 40333516)
10. D.J. Ceradini, A.R. Kulkarni, M.J. Callaghan, O.M. Tepper, N. Bastidas, and M.E. Kleinman Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 Nat Med 10 2004 858 864 (Pubitemid 39070860)
11. T. Asahara, T. Takahashi, H. Masuda, C. Kalka, D. Chen, and H. Iwaguro VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells EMBO J 18 1999 3964 3972 (Pubitemid 29335849)
12. E. Tanaka, N. Hattan, K. Ando, H. Ueno, Y. Sugio, and M.U. Mohammed Amelioration of microvascular myocardial ischemia by gene transfer of vascular endothelial growth factor in rabbits J Thorac Cardiovasc Surg 120 2000 720 728
13. W. Hiesinger, J.R. Frederick, P. Atluri, R.C. McCormick, N. Marotta, and J.R. Muenzer Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction J Thorac Cardiovasc Surg 140 2010 1174 1180
14. T.J. Rabelink, H.C. de Boer, E.J. de Koning, and A.J. van Zonneveld Endothelial progenitor cells: more than an inflammatory response? Arterioscler Thromb Vasc Biol 24 2004 834 838 (Pubitemid 38620859)
15. C. Urbich, and S. Dimmeler Endothelial progenitor cells functional characterization Trends Cardiovasc Med 14 2004 318 322 (Pubitemid 41110611)
16. M.C. Yoder Is endothelium the origin of endothelial progenitor cells? Arterioscler Thromb Vasc Biol 30 2010 1094 1103
17. M.K. Hagensen, P.M. Vanhoutte, and J.F. Bentzon Arterial endothelial cells: still the craftsmen of regenerated endothelium Cardiovasc Res 95 2012 281 289
18. Y. Zhang, S. Wong, J. Laflèche, S. Crowe, T.G. Mesana, and E.J. Suuronen In vitro functional comparison of therapeutically relevant human vasculogenic progenitor cells used for cardiac cell therapy J Thorac Cardiovasc Surg 140 2010 216 224 224.e1-4
19. E.J. Suuronen, J. Price, J.P. Veinot, K. Ascah, V. Kapila, and X.W. Guo Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function J Thorac Cardiovasc Surg 134 2007 1249 1258 (Pubitemid 47633641)
20. E. Sweeney, H. Lortat-Jacob, G. Priestley, B. Nakamoto, and T. Papayannopoulou Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells Blood 99 2002 44 51
21. L. Ye, H.K. Haider, R. Tan, W. Toh, P.K. Law, and W. Tan Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair Circulation 116 11 suppl 2007 I113 I120 (Pubitemid 47480778)